Vision and mission
Our vision is to be a leading company in providing antiviral therapeutics.
Our mission is to leverage our proprietary knowledge and extensive networks to provide an effective, novel therapy which targets coronavirus infection.
Delivering on our vision and mission rests on the high quality of our people, partners and proprietary product:
People – our team brings extensive knowledge and experience in successfully navigating the translation and commercialisation of products that improve human health.
Partnerships – our strong relationships with leading researchers and consultants ensure we can access the best science, research and innovation.
Proprietary product – developing and commercialising our novel Antiviral Triple Therapy (ATT) could help protect and improve the health and well-being of millions of people whilst generating a strong, scalable business model.